Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01871311
Title A Phase I Study of the BCR-ABL Tyrosine Kinase Inhibitor Nilontinib and Cetuximab in Patients With Solid Tumors That Can be Treated With Cetuximab
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Georgetown University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown Lombardi Comprehensive Cancer Center Washington District of Columbia 20007 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field